Koyfin Home > Directory > Health Care > Antares Pharma > Total Debt / Capital

Antares Pharma Total Debt / Capital Chart (ATRS)

Antares Pharma annual/quarterly Total Debt / Capital from 2017 to 2020.
  • Antares Pharma Total Debt / Capital for the quarter ending March 03, 2020 was $47m a -8.83% decrease of -4m year over year
  • Antares Pharma Total Debt / Capital for the last 12 months ending March 03, 2020 was $47m a -8.83% decrease of -4m year over year
  • Antares Pharma Annual Total Debt / Capital for 2019 was $46m a 15.47% increase of 7m from 2018
  • Antares Pharma Annual Total Debt / Capital for 2018 was $39m a -8.63% decrease of -3m from 2017
  • Antares Pharma Annual Total Debt / Capital for 2017 was $43m
Other Ratios Metrics:
  • Antares Pharma Other Liabilities for the quarter ending September 09, 2018 was $0m a 0.00% decrease of 0m year over year
  • Antares Pharma Total Debt / Equity for the quarter ending December 12, 2018 was $64m a -36.97% decrease of -24m year over year
View Chart On Koyfin

Quarterly ATRS Total Debt / Capital Data

03/2020$47m
12/2019$46m
09/2019$51m
06/2019$51m
03/2019$39m
12/2018$39m
09/2018$51m
06/2018$50m
03/2018$47m
12/2017$43m

Annual ATRS Total Debt / Capital Data

2019$46m
2018$39m
2017$43m